Complex assessment of cardioprotective actions of ischemic preconditioning: the influence of ischemia severity on the antiarrhythmic effect
- Authors: Petrishchev N.N.1, Tsirlin V.A.1, Vlasov T.D.1, Syrensky A.V.1, Sonin D.L.2, Minasian S.M.1, Galagudza M.M.1
-
Affiliations:
- I.P. Pavlov Federal Medical University
- I.P. Pavlov Federal Medical Universi
- Issue: Vol 1, No 2 (2001)
- Pages: 14-21
- Section: Basis medicine
- Published: 16.10.2025
- URL: https://journals.eco-vector.com/MAJ/article/view/693483
- DOI: https://doi.org/10.17816/MAJ693483
- ID: 693483
Cite item
Abstract
A protective effects of ischemic preconditioning (IPC) on subsequent prolonged myocardial ischemic/reperfusion damage were investigated using both in vivo rat model and isolated heart preparation. Myocardial infarct size, severity and duration of ischemia- and reperfusion-induced arrythmias, and a rate of intraischemic and postischemic contractile recovery were used as an end points of myocardial protection. Accordingly, two major aspects of cardioprotection afforded by IPC could be specified as antiarrythmic and infarct-limiting, i.e., antiischemic. A threshold of antiarrythmic effect of IPC appears to be lower than that of infarct-limiting potency. We failed to see any protection against reperfusion-induced arrythmias when coronary flow was reduced more then two-fold from its initial value. In contrast, IPC confers more early and complete intraischemic contractile recovery in the presence of severe reduction in coronary flow.
Keywords
About the authors
N. N. Petrishchev
I.P. Pavlov Federal Medical University
Author for correspondence.
Email: medaj@eco-vector.com
Russian Federation, St. Petersburg, 197022, 6/8 Lva Tolstogo St.
V. A. Tsirlin
I.P. Pavlov Federal Medical University
Email: medaj@eco-vector.com
Research Institute of Cardiology of the Ministry of Health Care
Russian Federation, St. Petersburg, 197022, 6/8 Lva Tolstogo St.T. D. Vlasov
I.P. Pavlov Federal Medical University
Email: medaj@eco-vector.com
Russian Federation, St. Petersburg, 197022, 6/8 Lva Tolstogo St.
A. V. Syrensky
I.P. Pavlov Federal Medical University
Email: medaj@eco-vector.com
Research Institute of Cardiology of the Ministry of Health Care
Russian Federation, St. Petersburg, 197022, 6/8 Lva Tolstogo St.D. L. Sonin
I.P. Pavlov Federal Medical Universi
Email: medaj@eco-vector.com
S. M. Minasian
I.P. Pavlov Federal Medical University
Email: medaj@eco-vector.com
Russian Federation, St. Petersburg, 197022, 6/8 Lva Tolstogo St.
M. M. Galagudza
I.P. Pavlov Federal Medical University
Email: medaj@eco-vector.com
Russian Federation, St. Petersburg, 197022, 6/8 Lva Tolstogo St.
References
- Гурин А. В., Молош А. И., Сидоренко Г. И. Прерывистая ишемия — уникальный адаптивный феномен. Перспектива новых путей фармакологического воздействия // Кардиология. 1997. Т. 6. С. 45–52.
- Коган А. Х. Хирургический метод моделирования коронароокклюзионного инфаркта и аневризмы сердца у крыс // Патологическая физиология и экспериментальная терапия. 1975. Т. 15. С. 79–82.
- Cave A. C., Collis C. S., Downey J. M., Hearse D. J. Improved functional recovery by ischemic preconditioning is not mediated by adenosine in the globally ischemic isolated rat heart // Cardiovasc. Res. 1993. Vol. 27. P. 663–668.
- Downey J. M., Liu J. S., Thornton J. D. Adenosine and the anti-infarct effects of preconditioning // Cardiovasc. Res. 1993. Vol. 27. P. 3–8.
- Ferrari R., Ceconi C., Curello S. et al. Myocardial damage during ischemia and reperfusion // Eur. Heart J. 1993. Vol. 14 (Suppl. G). P. 25–30.
- Fishbein M. C., Meerbaum S., Rit J. et al. Early phase acute myocardial infarction size quantification: validation of the triphenyltetrazolium chloride tissue enzyme staining technique // Am. Heart J. 1981. Vol. 101. P. 593–600.
- Himory N., Matsuura A. A simple technique for occlusion and reperfusion of coronary artery in conscious rats // Am. J. Physiol. 1989. Vol. 256. P. H1719–H1725.
- Huang C. H., Kim S. J., Ghalen B., Kudel R. K., Shen Y. T., Bishop S. P., Vatner S. F. An adenosine agonist and preconditioning shift the distribution of myocardial blood flow in conscious pigs // Am. J. Physiol. 1999. Vol. 276 (45). P. H368–H375.
- Janier M. F., Vanoverschelde J., Bergmann S. R. Ischemic preconditioning stimulates anaerobic glycolysis in the isolated rabbit heart // Am. J. Physiol. 1994. Vol. 267. P. H1353–H1360.
- Leiris J., Harding D. P., Pestre S. The isolated rat heart: a model for studying myocardial hypoxia or ischemia // Basic Res. Cardiol. 1984. Vol. 79 (3). P. 315–323.
- Li G. C., Vasquez J. A., Gallagher K. P., Lucchesi B. R. Myocardial protection with preconditioning // Circulation. 1990. Vol. 82. P. 609–619.
- Liu Y., Downey J. M. Ischemic preconditioning protects against infarction in rat heart // Am. J. Physiol. 1992. Vol. 263. P. H1107–H1112.
- Murry C. E., Jennings R. B., Reimer K. A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium // Circulation. 1986. Vol. 74. P. 1124–1136.
- Ottani F., Galvani M., Ferrini D., Nicolini F. A. Clinical relevance of prodromal angina before acute myocardial infarction // Int. J. Cardiol. 1999. Vol. 68 (Suppl. 1). P. S103–S108.
- Oxman T., Arad M., Klein R., Avazov N., Rabinowitz B. Limb ischemia preconditions the heart against reperfusion tachyarrhythmia // Am. J. Physiol. 1997. Vol. 273 (4 Pt 2). P. 1707–1712.
- Piper H. M., Garcia-Dorado D., Ovize M. A fresh look at reperfusion injury // Cardiovasc. Res. 1998. Vol. 38. P. 291–300.
- Van Winkle D. M., Thornton J., Downey D. M. et al. The natural history of preconditioning: cardioprotection depends on duration of transient ischemia and time to subsequent ischemia // Coronary Art. Dis. 1991. Vol. 2. P. 613–619.
- Walker M. J., Curtis M. J., Hearse D. J. et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischemia, infarction, and reperfusion // Cardiovasc. Res. 1988. Vol. 22. P. 447–455.
- Yellon D. M., Baxter G. F., Garcia-Dorado D., Heusch G., Sumeray M. S. Ischemic preconditioning: present position and future directions // Cardiovasc. Res. 1998. Vol. 37. P. 21–33.
Supplementary files
